Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Radiotherapy Market Size to Reach USD 7.65 Billion in 2027 | Increasing Global Incidence of Cancer, Rising Use of Radiotherapy in Combination with Other Treatment Approaches are Some Key Factors Driving Industry Demand, says Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

11 Aug, 2021, 14:09 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, BC, Aug. 11, 2021  /PRNewswire/ -- The global radiotherapy market size is expected to reach USD 7.65 Billion in 2027 at a CAGR of 3.4% during the forecast period, according to the latest report by Emergen Research. Rising prevalence of cancer worldwide, increasing adoption of radiotherapy for treatment of various cancers, and growing awareness among patients regarding the benefits of radiotherapy are key factors expected to drive market revenue growth over the forecast period. In addition, radiotherapy minimizes the damage to surrounding healthy tissues and can be combined with chemotherapy to make other treatment approaches more effective. This has resulted in increased adoption of radiotherapy as a curative or adjuvant treatment approach and is expected to further contribute to the revenue growth of the market going ahead.

Radiotherapy is a treatment approach that utilizes high dosage of radiations to destroy cancer cells and shrink tumors. Radiotherapy has proven to be effective in the treatment of various types of cancers and some non-cancerous tumors. Radiation therapy often uses X-rays but protons and other energy types can also be used. High-energy beams from a machine are aimed at precise points in the body to kill cancer cells while minimizing the damage to surrounding healthy cells and tissues.

Radiotherapy is also done to reduce the risk of cancer coming back after surgeries and to relieve symptoms when the cure for particular type of cancer is not available. Recent technological advancements in radiotherapy have made the treatment more precise, improved the patient outcomes significantly, reduced cost of the procedure, and increased efficiency of treatment. This is expected to further boost its adoption across the globe and contribute to the revenue growth of the market going ahead.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/49

However, lack of adequate healthcare facilities in developing and underdeveloped countries, shortage of skilled professionals, complexity of the treatment and radiotherapy devices, low healthcare expenditure, and low awareness among patients about radiotherapy are some key factors expected to restrain market growth to a certain extent over the forecast period. In addition, risk of radiation exposure associated with the treatment and growing incidences of side effects such as nausea and vomiting are some other factors that can hamper market growth going ahead.

Some Key Highlights from the Report:

  • External beam radiotherapy product segment is expected to register significant revenue growth over the forecast period owing to rapid technological advancements in radiotherapy machines, ability to deliver precise radiation dosage, minimal damage to surrounding healthy tissues, and increasing use of linear accelerator systems.
  • Breast cancer segment is expected to register robust revenue CAGR over the forecast period owing to increasing incidence of breast cancer in women worldwide, rising use of brachytherapy to deliver precise and high concentration dosage to target tissues, growing preference for radiotherapy owing to minimal radiation risk to healthy breast tissues, and rapid advancements to develop effective treatment procedures for breast cancer.
  • Hospitals segment accounted for largest revenue share in the global market in 2019 and is expected to register significant revenue growth going ahead. Revenue growth of the segment can be attributed to increasing number of cancer patients preferring hospitals for diagnosis and treatment, availability of and accessibility to state-of-the-art healthcare facilities, and implementation of favorable reimbursement policies.
  • Asia Pacific market revenue is expected to expand significantly over the forecast period owing to large population of target diseases, increasing medical tourism, advancements and improvements in healthcare facilities, rising awareness regarding radiotherapy as an effective cancer treatment approach, and increasing presence of key players in the region.
  • Major companies in the market include Varian Medical Systems, Inc., Elekta, Accuray Incorporated, Ion Beam Applications S.A., Panacea Medical Technologies Pvt. Ltd., ViewRay, Inc., IsoRay Medical, Inc., Provision Healthcare, Hitachi Ltd., Mevion Medical Systems, Inc., and Reflexion Medical.
  • In April 2021, Varian Medical Systems, Inc. announced a strategic partnership with Google Cloud to build an AI-powered diagnostic platform to create AI models for organ segmentation and automate radiation oncology workflow to accelerate the fight against cancer.
  • In June 2021, first-ever public radiotherapy facility opened in Niger providing access to critical patients and marked an important milestone in the country's fight against cancer. The facility has been commissioned in association with the International Atomic Energy Agency (IAEA) and is expected to offer radiotherapy services to nearly 600 cancer patients from Niger and neighboring West African countries annually.
  • In July 2021, Russian scientists developed a novel method for the evaluation of radiotherapy effectiveness in cervical cancer patients by using scanning electron microscopy to assess the morphological changes in red blood cells due to radiation. The technique, in future, can also be used to understand the role of viruses, vesicles, and red blood cells in the development and progression of cervical cancer. The study was published in the International Journal of Biomedicine.

Buy your Exclusive copy [Make Payment ]@ https://www.emergenresearch.com/select-license/49

For the purpose of this report, Emergen Research has segmented the global radiotherapy market on the basis of product, type, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2017–2027)

  • External Beam Radiotherapy Product
    • Linear Accelerators (LINAC)
      • Conventional LINAC
      • Stereotactic Advanced Electron/Cobalt-60 LINAC
        • CyberKnife
        • Gamma Knife
        • TomoTherapy
      • Particle Therapy Systems
        • Cyclotrons
        • Synchrotrons
        • Synchrocyclotrons
      • Conventional Cobalt-60 Teletherapy Units
  • Internal Beam Radiotherapy/Brachytherapy Products
    • Seeds
    • Applicators
    • Afterloaders
    • Electronic Brachytherapy Products
  • Systemic Radiotherapy
    • Iobenguane-131
    • Samarium-153
    • Rhenium-186
    • Yttrium-90
    • Radium-223
    • Phosphorous-32
    • Radio-Labelled Antibodies

Types Outlook (Revenue, USD Billion; 2017–2027)

  • External Beam Radiotherapy
    • Image-guided Radiotherapy (IGRT)
    • Intensity-modulated Radiotherapy (IMRT)
      • TomoTherapy
      • Volumetric Modulated Arc Therapy (VMAT)
    • Stereotactic Therapy
    • 3D Conformal Radiotherapy (3D-CRT)
    • Particle Beam Therapy (Heavy-ion and Proton Therapy)
  • Internal Beam Radiotherapy/Brachytherapy
    • Low-dose-rate (LDR) Brachytherapy
    • High-dose-rate (HDR) Brachytherapy
    • Pulsed-dose-rate (PDR) Brachytherapy
  • Systemic Radiotherapy
    • Intravenous Radiotherapy
    • Oral Radiotherapy
    • Instillation Radiotherapy

Applications Outlook (Revenue, USD Billion; 2017–2027)

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Spine Cancer
  • Brain Cancer
  • Pediatric Cancer
  • Gynecological Cancer
  • Cervical Cancer
  • Penile Cancer
  • Head and Neck Cancer

End Use Outlook (Revenue, USD Billion; 2017–2027)

  • Hospitals
  • Independent Radiotherapy Centers

Have a look at Report Description and Table of Contents of Market Research Report@ https://www.emergenresearch.com/industry-report/radiotherapy-market

Regional Outlook (Revenue, USD Billion; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Explore more reports offered by Emergen Research:

The global patient engagement solutions market is estimated to grow at a CAGR of 15.1% from USD 11.77 billion in 2019 to USD 41.20 billion in 2027. The patient engagement solutions market is driven mainly by the growing use of electronic health records for patient-centered care and the adoption of mobile health apps.

The global regenerative medicine market is estimated to grow at a CAGR of 9.3% from USD 3.05 billion in 2019 to USD 6.49 billion in 2027. A strong product pipeline and government and private investment to support research are expected to fuel growth in clinical trials.

The global next generation sequencing market is forecasted to grow at a rate of 10.9% from USD 9.67 Billion in 2019 to USD 23.59 Billion in 2027. The reduction of sequencing costs is projected to lead to a large number of clinical areas in the Next Generation Sequencing (NGS).

The global RFID in healthcare market is forecasted to grow at a rate of 15.0% from USD 3.69 Billion in 2019 to USD 12.89 Billion in 2027. Certain factors, such as a growing operational cost savings necessity, the implementation of RFID in health care, and patient safety requirements, are driving the market.

The global Newborn Screening Market is forecasted to grow at a rate of 10.3% in terms of value, from USD 1.03 billion in 2019 to reach USD 2.27 billion by 2027. Growing neonatal population base, increasing Newborn congenital disease events, favorable government initiatives & regulations, and developments in technology are expected to serve as critical drivers of the Newborn screening market.

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com 
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com 
Facebook | LinkedIn | Twitter | Blogs 
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-radiotherapy-market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg  

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.